Search

Yared Tekabe Phones & Addresses

  • Cortlandt Manor, NY
  • Bronx, NY
  • Yonkers, NY
  • 245 Garden St, Cambridge, MA 02138
  • Teaneck, NJ
  • Needham, MA

Work

Company: Center for cardiovascular molecular imaging, columbia university medical center 2008 Position: Research scientist

Education

School / High School: Northeastern University- Boston, MA 2005 Specialities: PH.D in BIOMEDICAL SCIENCES

Resumes

Resumes

Yared Tekabe Photo 1

Yared Tekabe

View page
Work:
Center for Cardiovascular Molecular Imaging, Columbia University Medical Center

2008 to 2000
Research Scientist

Center for Cardiovascular Molecular Imaging, Columbia University Medical Center
New York, NY
2005 to 2008
Post-Doctoral Fellow

Center for Cardiovascular Targeting, Northeastern University
Boston, MA
2000 to 2005
Graduate Student

Human Anatomy and Physiology Laboratory, Northeastern University
Boston, MA
Sep 2003 to Dec 2003
Teaching Assistant

Immunology, Northeastern University
Boston, MA
Sep 2002 to Dec 2002
Teaching Assistant

Molecular Medicine
Cambridge, MA
1998 to 2001
Research Associate, Genetics Institute

Education:
Northeastern University
Boston, MA
2005
PH.D in BIOMEDICAL SCIENCES

Northeastern University
Boston, MA
1999
M.S in BIOMEDICAL SCIENCES

Northeastern University
Boston, MA
1995
B.S in BIOTECHNOLOGY

Publications

Us Patents

Antibody To Rage And Uses For In Vivo Imaging Or For Targeting Therapy

View page
US Patent:
20110311448, Dec 22, 2011
Filed:
Oct 31, 2008
Appl. No.:
12/734449
Inventors:
Ann Marie Schmidt - Franklin Lakes NJ, US
Lynne Johnson - New York NY, US
Barry Hudson - New York NY, US
Yared Tekabe - Yonkers NY, US
International Classification:
A61K 49/00
A61P 9/10
A61K 39/395
C07K 16/00
C07K 16/18
US Classification:
424 91, 5303879, 5303913, 5303917, 4241781
Abstract:
This invention discloses an antibody which is raised to a peptide, the sequence of which is: N-R-N-G-K-E-T-K-S-N-Y-R-V-R-V-Y-Q-I-P, N-R-R-G-K-E-V-K-S-N-Y-R-V-R-V-Y-Q-I-P, S-R-N-G-K-E-T-K-S-N-Y-R-V-Q-V-Y-Q-I-P, N-R-R-G-K-E-V-K-S-N-Y-R-V-R-V-Y-Q-I-C, or Ac-N-R-R-G-K-E-V-K-S-N-Y-R-V-R-V-Y-Q-I-C-amide. This antibody can be labeled with an imageable marker or linked to an agent. This antibody can be a monoclonal antibody. The invention also includes a method for determining the location of receptor advanced glycation endproduct (RAGE) in a subject comprising administering the antibody labeled with an imageable marker and detecting the location of the labeled antibody in the subject thereby determining the location of RAGE in the subject. This invention further describes a method for treating a RAGE-related disorder in a subject comprising administering to the subject a therapeutically effective amount of the antibody which binds to the above-described epitope linked to an agent.

In Vivo Imaging Of Matrix Metalloproteinases In Lung Disease

View page
US Patent:
20210008231, Jan 14, 2021
Filed:
May 19, 2017
Appl. No.:
16/303599
Inventors:
- New York NY, US
Lynne JOHNSON - New York NY, US
Monica GOLDKLANG - Demarest NJ, US
Yared TEKABE - Bronx NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 51/04
C07B 59/00
Abstract:
The present invention provides a method of imaging a subject's lung which comprises contacting the subject's lung with a matrix metalloproteinase inhibitor labeled with a radioisotope under conditions such that the inhibitor binds to matrix metalloproteinase in the lung, and then imaging the radiolabeled inhibitor bound to matrix metalloproteinase in the subject's lung.The invention also provides Ro 32-3555 labeled with a radioisotope.
Yared D Tekabe from Cortlandt Manor, NY, age ~52 Get Report